Going Private – A Road Ahead for U.S.-Listed Chinese Companies? 中概股私有化之路

On March 10, SEC named five U.S.-listed Chinese companies that could face delisting if they do not hand over detailed audit documents to U.S. regulators. Under the current regulatory environment, is going private a road ahead for the over 270 U.S.-listed Chinese companies?

Please join us to discuss pragmatic issues in going-private transactions. MoFo partners Marcia Ellis, Ruomu Li, Ke Huang, and Michael O’Bryan will share tips from their privatization experience, and partner Chen Zhu will moderate the discussion.

Topics will include:

• HFCAA and Current Context for Going Private
• Key Procedural Steps and Indicative Timeline
• Strategic Considerations:
  
  • Forming or Joining a Consortium
  • Initial Approaches and Disclosure
  • Working with Special Committees
• Next Step: Listing in Hong Kong or Mainland China?

To access the full recording of the webinar, please complete and submit the form below.

2022年3月22日, 北京时间上午10:30-11:30

3月10日，美国证券交易委员会列出五家在美上市的中国公司，如果不按时递交财务审计文件，将可能面临强制退市。在目前的监管环境下，对于超过270家中概股公司来说，私有化是否将成为其眼下的出路？

美富诚邀您参加此次网络研讨会，共同探讨私有化交易的实务问题。本所合伙人Marcia Ellis、李若木、黄克和Michael O'Bryan律师将分享私有化方面的经验和见解。本所合伙人朱晨昊律师将主持讨论。耿文澜律师将协助观众进行问答。

此次研讨会的主题将包括:

• 《外国公司问责法案》（HFCAA）与当前的私有化背景
• 私有化的主要步骤及时间表
• 战略考量因素
  
  • 建立或参与买方财团
  • 初步方法与相关披露
  • 董事会特别委员会
• 下一步：在香港或中国大陆上市？

请填写表格，查看中文研讨会的回放视频。